Comprehensive next-generation sequencing reveals double primary colorectal carcinoma missed by diagnostic imaging: A case report  

作　　者：Yan-Jun Qu Qian-Shi Zhang Bo Wang Feng Zhang Evenki Pan Chun-Yan Zhao Si-Ye Liu Li-Ping Fang 

机构地区：[1]Department of Medical Oncology,The Second Hospital of Dalian Medical University,Dalian 116023,Liaoning Province,China [2]Department of Gastrointestinal Surgery,The Second Hospital of Dalian Medical University,Dalian 116023,Liaoning Province,China [3]Department of Medical,Nanjing Geneseeq Technology Inc.,Nanjing 211500,Jiangsu Province,China

出　　处：《World Journal of Gastrointestinal Oncology》2023年第10期1823-1828,共6页世界胃肠肿瘤学杂志（英文版）（电子版）

摘　　要：BACKGROUND Multiple primary colorectal carcinoma(MPCC)is a rare clinical disease,which is challenging to differentiate from metastatic disease using histopathological methods.Next-generation sequencing(NGS)has been employed to identify multiple primary cancers.CASE SUMMARY This study a rare case of a 63-year-old male patient diagnosed with MPCC by targeted NGS,which was initially missed by radiological evaluation.The patient was found to have two tumors located on the surface of the colorectum which had distinct genomic alterations.Based on wild-type KRAS detected in the unresected tumor,the patient benefited from the epidermal growth factor receptor(EGFR)inhibitor cetuximab treatment,but developed novel mutations including KIF5B-RET fusion,which provides a possible resistance mechanism to anti-EGFR therapy.CONCLUSION Our case highlights the necessity of using genetic testing for primary tumor diagnosis and the application of serial plasma circulating tumor DNA profiling for dynamic disease monitoring.

关 键 词：Multiple primary colorectal carcinoma Next-generation sequencing CETUXIMAB RET fusion Case report 

分 类 号：R735.8[医药卫生—肿瘤]